Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radica Z Alicic

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Diabetes|July 21, 2021
Glycemic Variability and KIM-1-Induced Inflammation in the Diabetic KidneyKatherine R Tuttle, Radica Z Alicic
Seminars in Dialysis|April 9, 2010
Management of the diabetic patient with advanced chronic kidney diseaseRadica Z Alicic, Katherine R Tuttle
Cardiology Clinics|June 29, 2025
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) ConditionsRadica Z Alicic, Joshua J Neumiller
Journal of Clinical Medicine|January 11, 2024
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney DiseaseRadica Z Alicic, Joshua J Neumiller
Advances in Chronic Kidney Disease|March 8, 2014
Novel therapies for diabetic kidney diseaseRadica Z Alicic, Katherine R Tuttle
Advances in Chronic Kidney Disease|February 27, 2013
Direct and indirect effects of obesity on the kidneyRadica Z Alicic, Ramu Patakoti, Katherine R Tuttle
Kidney Medicine|January 6, 2023
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United StatesSusanne B Nicholas, Radica Z Alicic, Jenny Shen
Annual Review of Medicine|November 21, 2025
Therapeutic Considerations in Preventing Chronic Kidney DiseaseSusanne B Nicholas, Niloofar Nobakht, Radica Z Alicic
American Journal of Physiology. Renal Physiology|August 16, 2018
GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-sideBrad P Dieter, Radica Z Alicic, Katherine R Tuttle
Advances in Chronic Kidney Disease|March 28, 2018
Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney DiseaseRadica Z Alicic, Emily J Johnson, Katherine R Tuttle
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Diabetes|July 21, 2021
Glycemic Variability and KIM-1-Induced Inflammation in the Diabetic KidneyKatherine R Tuttle, Radica Z Alicic
Seminars in Dialysis|April 9, 2010
Management of the diabetic patient with advanced chronic kidney diseaseRadica Z Alicic, Katherine R Tuttle
Cardiology Clinics|June 29, 2025
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) ConditionsRadica Z Alicic, Joshua J Neumiller
Journal of Clinical Medicine|January 11, 2024
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney DiseaseRadica Z Alicic, Joshua J Neumiller
Advances in Chronic Kidney Disease|March 8, 2014
Novel therapies for diabetic kidney diseaseRadica Z Alicic, Katherine R Tuttle
Advances in Chronic Kidney Disease|February 27, 2013
Direct and indirect effects of obesity on the kidneyRadica Z Alicic, Ramu Patakoti, Katherine R Tuttle
Kidney Medicine|January 6, 2023
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United StatesSusanne B Nicholas, Radica Z Alicic, Jenny Shen
Annual Review of Medicine|November 21, 2025
Therapeutic Considerations in Preventing Chronic Kidney DiseaseSusanne B Nicholas, Niloofar Nobakht, Radica Z Alicic
American Journal of Physiology. Renal Physiology|August 16, 2018
GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-sideBrad P Dieter, Radica Z Alicic, Katherine R Tuttle
Advances in Chronic Kidney Disease|March 28, 2018
Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney DiseaseRadica Z Alicic, Emily J Johnson, Katherine R Tuttle
Pageof 5